Mark Drost

570 total citations
16 papers, 302 citations indexed

About

Mark Drost is a scholar working on Pathology and Forensic Medicine, Cancer Research and Genetics. According to data from OpenAlex, Mark Drost has authored 16 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 13 papers in Cancer Research and 7 papers in Genetics. Recurrent topics in Mark Drost's work include Genetic factors in colorectal cancer (14 papers), Cancer Genomics and Diagnostics (13 papers) and Genomics and Rare Diseases (4 papers). Mark Drost is often cited by papers focused on Genetic factors in colorectal cancer (14 papers), Cancer Genomics and Diagnostics (13 papers) and Genomics and Rare Diseases (4 papers). Mark Drost collaborates with scholars based in Netherlands, Denmark and Australia. Mark Drost's co-authors include Niels de Wind, Lene Juel Rasmussen, Robert M.W. Hofstra, Sean V. Tavtigian, José B.M. Zonneveld, Hans Morreau, Brigitte Royer‐Pokora, Emily Rayner, Hans F. A. Vasen and Carli M.J. Tops and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Cancer Research and Carcinogenesis.

In The Last Decade

Mark Drost

15 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Drost Netherlands 11 214 165 132 76 57 16 302
Kristi Kosarin United States 4 121 0.6× 96 0.6× 128 1.0× 203 2.7× 72 1.3× 5 374
Zohreh Ketabi Denmark 7 94 0.4× 76 0.5× 77 0.6× 42 0.6× 58 1.0× 8 211
Fernando Bellido Spain 6 176 0.8× 119 0.7× 109 0.8× 43 0.6× 118 2.1× 8 280
Antoine Rousselin France 8 88 0.4× 132 0.8× 296 2.2× 266 3.5× 73 1.3× 11 471
Reetta Kariola Finland 13 473 2.2× 291 1.8× 156 1.2× 102 1.3× 235 4.1× 15 520
Angélina Legros France 5 73 0.3× 124 0.8× 147 1.1× 189 2.5× 62 1.1× 9 285
Baptiste Brault France 4 71 0.3× 116 0.7× 133 1.0× 183 2.4× 62 1.1× 5 271
Alessia Fiorino Italy 9 72 0.3× 76 0.5× 130 1.0× 129 1.7× 118 2.1× 17 281
Saundra Buys United States 3 46 0.2× 80 0.5× 83 0.6× 109 1.4× 48 0.8× 3 192
Hicham Ouchene Netherlands 4 219 1.0× 156 0.9× 47 0.4× 53 0.7× 190 3.3× 6 287

Countries citing papers authored by Mark Drost

Since Specialization
Citations

This map shows the geographic impact of Mark Drost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Drost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Drost more than expected).

Fields of papers citing papers by Mark Drost

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Drost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Drost. The network helps show where Mark Drost may publish in the future.

Co-authorship network of co-authors of Mark Drost

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Drost. A scholar is included among the top collaborators of Mark Drost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Drost. Mark Drost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Srebniak, Malgorzata I., Marjolein J.A. Weerts, Marieke Joosten, et al.. (2025). Chorionic Villus Sampling for Rapid Confirmation of High‐Risk NIPT Results for Trisomy 21, 18, and 13. Prenatal Diagnosis. 45(8). 988–993.
2.
Rayner, Emily, Cristina Fortuño, Mark Drost, et al.. (2022). Predictive functional assay‐based classification of PMS2 variants in Lynch syndrome. Human Mutation. 43(9). 1249–1258. 5 indexed citations
3.
4.
Drost, Mark, Scott D. Kathe, Fabienne M.G.R. Calléja, et al.. (2020). Two integrated and highly predictive functional analysis-based procedures for the classification of MSH6 variants in Lynch syndrome. Genetics in Medicine. 22(5). 847–856. 16 indexed citations
5.
Thompson, Bryony A., Rhiannon Walters, Michael T. Parsons, et al.. (2020). Contribution of mRNA Splicing to Mismatch Repair Gene Sequence Variant Interpretation. Frontiers in Genetics. 11. 798–798. 11 indexed citations
6.
Ruano, Dina, Mark Drost, Niels de Wind, et al.. (2020). Digenic inheritance of MSH6 and MUTYH variants in familial colorectal cancer. Genes Chromosomes and Cancer. 59(12). 697–701. 10 indexed citations
7.
Gool, Inge C. van, Emily Rayner, Elisabeth M. Osse, et al.. (2018). Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues. Clinical Cancer Research. 24(13). 3197–3203. 58 indexed citations
8.
Dominguez–Valentin, Mev, Mark Drost, Christina Therkildsen, et al.. (2014). Functional implications of the p.Cys680Arg mutation in the MLH1 mismatch repair protein. Molecular Genetics & Genomic Medicine. 2(4). 352–355. 1 indexed citations
9.
Farrell, Michael, David J. Hughes, Mark Drost, et al.. (2013). Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicity. Familial Cancer. 12(4). 741–747. 2 indexed citations
10.
11.
Drost, Mark, Anne Lützen, Daniel Ferreira, et al.. (2013). Genetic screens to identify pathogenic gene variants in the common cancer predisposition Lynch syndrome. Proceedings of the National Academy of Sciences. 110(23). 9403–9408. 16 indexed citations
12.
Drost, Mark, et al.. (2013). Inactivation of DNA Mismatch Repair by Variants of Uncertain Significance in the PMS2 Gene. Human Mutation. 34(11). 1477–1480. 22 indexed citations
13.
Liberti, Sascha Emilie, Anne Lützen, Mark Drost, et al.. (2012). Functional characterization ofMLH1missense variants identified in lynch syndrome patients. Human Mutation. 33(12). 1647–1655. 15 indexed citations
14.
Rasmussen, Lene Juel, Brigitte Royer‐Pokora, Mark Drost, et al.. (2012). Pathological assessment of mismatch repair gene variants in Lynch syndrome: Past, present, and future. Human Mutation. 33(12). 1617–1625. 48 indexed citations
15.
Drost, Mark, et al.. (2011). A rapid and cell-free assay to test the activity of lynch syndrome-associated MSH2 and MSH6 missense variants. Human Mutation. 33(3). 488–494. 34 indexed citations
16.
Drost, Mark, Linda van Dijk, Hans Morreau, et al.. (2009). A cell-free assay for the functional analysis of variants of the mismatch repair protein MLH1. Human Mutation. 31(3). 247–253. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristi Kosarin Breakdown of academic impact, for papers by Zohreh Ketabi Breakdown of academic impact, for papers by Fernando Bellido Breakdown of academic impact, for papers by Antoine Rousselin Breakdown of academic impact, for papers by Reetta Kariola Breakdown of academic impact, for papers by Angélina Legros Breakdown of academic impact, for papers by Baptiste Brault Breakdown of academic impact, for papers by Alessia Fiorino Breakdown of academic impact, for papers by Saundra Buys Breakdown of academic impact, for papers by Hicham Ouchene
Rankless by CCL
2026